2024    2023    2022    2021    2020    2019    2018    2017    2016   

2021

Articles

21 - 

A descriptive, retrospective case series of patients with factitious disorder imposed on self

Antoine Berar, Guillaume Bouzille, Patrick Jego, Jean-Sebastien Allain

BMC Psychiatry, 2021, 21 (1), pp.588.

DOI : https://doi.org/10.1186/s12888-021-03582-8

Pubmed : 34814866

 

22 - 

Systematic Nasogastric Tube Decompression Following Pancreaticoduodenectomy-Is it Safe?-Reply

Damien Bergeat, Laurent Sulpice

JAMA Surgery, 2021, 156 (3), pp.293.

DOI : https://doi.org/10.1001/jamasurg.2020.5678

Pubmed : 33377896

 

23 - 

Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery

Elsa Besse-Pinot, Bruno Pereira, Franck Durif, Maria Livia Fantini, Elodie Durand et al.

Neurology, 2021, 97 (20), pp.e1994-e2006.

DOI : https://doi.org/10.1212/WNL.0000000000012862

Pubmed : 34667082

 

24 - 

One year prognostic value of B-lines in dyspnoeic patients

Auriane Bidaut, Arnaud Hubert, Marion Charton, Elise Paven, Christophe Leclercq et al.

ESC Heart Failure, 2021, 8 (3), pp.1759-1766.

DOI : https://doi.org/10.1002/ehf2.12739

Pubmed : 33704921

 

25 - 

Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases A Prospective, Open-label, Randomized, Controlled Trial

Karim Boudjema, Clara Locher, Charles Sabbagh, Pablo Ortega-Deballon, Bruno Heyd et al.

Annals of Surgery, 2021, 273 (1), pp.49-56.

DOI : https://doi.org/10.1097/SLA.0000000000003848

Pubmed : 32209911

 

26 - 

Reply to Papamichael, K., & Cheifetz, A. S. (2020). Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology

Guillaume Bouguen, Tanguy Brunet

Reply to Papamichael, K., & Cheifetz, A. S. (2020). Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. Clinical Gastroenterology and Hepatology, 2021, 19 (4), pp.855-856.

DOI : https://doi.org/10.1016/j.cgh.2020.06.013

Pubmed : 33249012

 

27 - 

A visual analogue scale for food intake as a screening test for malnutrition in the primary care setting: Prospective non-interventional study

Gwenhaël Bouëtté, Maxime Esvan, Katharina Apel, Ronan Thibault

Clinical Nutrition, 2021, 40 (1), pp.174-180.

DOI : https://doi.org/10.1016/j.clnu.2020.04.042

Pubmed : 32430249

 

28 - 

Bacterial gut dysbiosis is associated with Crohn’s disease symptoms but not with elevated fecal calprotectin

Sylvie Buffet-Bataillon, Céline Landreau, Laurent Siproudhis, Vincent Cattoir, Guillaume Bouguen et al.

Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (2), pp.101669.

DOI : https://doi.org/10.1016/j.clinre.2021.101669

Pubmed : 33744412

 

29 - 

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial

Christophe Bureau, Dominique Thabut, Caroline Jezequel, Isabelle Archambeaud, Louis D’alteroche et al.

Annals of Internal Medicine, 2021, 174 (5), pp.633-640.

DOI : https://doi.org/10.7326/M20-0202

Pubmed : 33524293

 

30 - 

EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)

Haran Burri, Christoph Starck, Angelo Auricchio, Mauro Biffi, Mafalda Burri et al.

EP-Europace, 2021, 23 (7), pp.983-1008.

DOI : https://doi.org/10.1093/europace/euaa367

Pubmed : 33878762